1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
申请人:AtheroGenics, Inc.
公开号:US07202247B2
公开(公告)日:2007-04-10
The invention relates to compounds, pharmaceutical compositions and methods of using compounds of the general formula
or its pharmaceutically acceptable salt or ester, wherein the substituents are defined in the application.
[EN] 1,3-BIS-(SUBSTITUTED-PHENYL)-2-PROPYN-1-ONES AND THEIR USE TO TREAT DISORDERS<br/>[FR] 1,3-BIS-(PHENYL-SUBSTITUE)-2-PROPYNE-1-ONES ET LEUR UTILISATION POUR LE TRAITEMENT D'AFFECTIONS
申请人:ATHEROGENICS INC
公开号:WO2003053359A2
公开(公告)日:2003-07-03
The invention relates to compounds, pharmaceutical compositions and the use of compounds of the general formula, or its pharmaceutically acceptable salt or ester, wherein the substituents are defined in the application.
1,3-Bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
申请人:——
公开号:US20030232877A1
公开(公告)日:2003-12-18
The invention relates to compounds, pharmaceutical compositions and methods of using compounds of the general formula
1
or its pharmaceutically acceptable salt or ester, wherein the substituents are defined in the application.